Share on:
Arcam acquired its strategic contract manufacturing partner, DiSanto Technology, for US $15.8MM in cash and stock. For the last 12 months, DiSanto generated revenue of ~$12MM. DiSanto will become a subsidiary of Arcam and will continue operations under its existing management. (Source: Arcam)
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell